Gang Wu, Hao Hu, Yong Huang, Ruibing Feng, Chaowen Li, Yizheng Huang, Chao Li, Haitao Zhang
Department of Spinal Surgery, Hubei Provincial Hospital of TCM, Wuhan, China.
Affiliated Hospital of Hubei University of Chinese Medicine, Wuhan, China.
Front Pharmacol. 2022 Jun 15;13:905576. doi: 10.3389/fphar.2022.905576. eCollection 2022.
Triptolide, a diterpene triepoxide, is a pharmacologically active compound isolated from a Chinese medicinal herb Hook F (TwHF). Triptolide has attracted considerable attention in recent times due to its multiple biological and pharmaceutical activities, with an emphasis on therapeutic importance in the treatment of diverse disorders. With essential medicinal implications, TwHF's extracts have been used as anti-inflammatory, antiproliferative, antioxidative, and immunosuppressive agents for centuries, with continuous and relevant modifications to date to enhance its utility in several diseases and pathophysiology. Here, in this review, we accentuate the studies, highlighting the effects of triptolide on treating bone-related disorders, both inflammatory and cancerous, particularly osteosarcoma, and their manifestations. Based on this review, future avenues could be estimated for potential research strategies, molecular mechanisms, and outcomes that might contribute toward reinforcing new dimensions in the clinical application of triptolide in treating bone-related disorders.
雷公藤甲素是一种二萜三环氧化物,是从一种中草药雷公藤中分离出的具有药理活性的化合物。近年来,雷公藤甲素因其多种生物学和药学活性而备受关注,尤其在治疗多种疾病方面具有重要的治疗意义。由于具有重要的药用价值,雷公藤提取物几个世纪以来一直被用作抗炎、抗增殖、抗氧化和免疫抑制剂,并且至今仍在不断进行相关改进,以提高其在多种疾病和病理生理学中的效用。在此综述中,我们着重介绍相关研究,突出雷公藤甲素在治疗炎症性和癌性骨相关疾病,特别是骨肉瘤及其表现方面的作用。基于此综述,可以预测未来在潜在研究策略、分子机制和结果方面的研究方向,这些可能有助于拓展雷公藤甲素在治疗骨相关疾病临床应用中的新维度。